Assembly Biosciences, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ASMB Nasdaq 2836 www.assemblybio.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Assembly Biosciences, Inc.

Assembly Biosciences First Quarter 2025 Earnings: Beats Expectations - May 10th, 2025 12:50 pm
Assembly Biosciences (ASMB) Reports Q1 Loss, Tops Revenue Estimates - May 8th, 2025 9:40 pm
Assembly Biosciences: Q1 Earnings Snapshot - May 8th, 2025 8:36 pm
Assembly Biosciences Reports First Quarter 2025 Financial Results and Recent Updates - May 8th, 2025 8:05 pm
New Preclinical Data for Assembly Biosciences’ Oral Hepatitis D Virus Entry Inhibitor ABI-6250 and Next-Generation Hepatitis B Virus Capsid Assembly Modulator ABI-4334 Presented at the EASL Congress 2025 - May 7th, 2025 12:00 pm
Assembly Biosciences (ASMB) Soars 24.0%: Is Further Upside Left in the Stock? - May 5th, 2025 1:47 pm
Assembly Biosciences (NASDAQ:ASMB) Is In A Good Position To Deliver On Growth Plans - May 2nd, 2025 11:15 am
Assembly Biosciences Presents New Data Highlighting Long-Acting Herpes Simplex Virus Candidate ABI-5366 and Genital Herpes Prevalence and Treatment Patterns at the 2025 ESCMID Congress - Apr 9th, 2025 6:00 am
Down -22.6% in 4 Weeks, Here's Why Assembly Biosciences (ASMB) Looks Ripe for a Turnaround - Apr 8th, 2025 1:35 pm
Assembly Biosciences (ASMB) Upgraded to Buy: What Does It Mean for the Stock? - Mar 26th, 2025 4:00 pm
Assembly Biosciences Full Year 2024 Earnings: Beats Expectations - Mar 22nd, 2025 1:18 pm
Assembly Biosciences Reports Year End 2024 Financial Results and Recent Highlights - Mar 20th, 2025 8:05 pm
Assembly Biosciences Insiders Placed Bullish Bets Worth US$679.4k - Mar 19th, 2025 10:47 am
Is Assembly Biosciences, Inc. (ASMB) Among Stocks With At Least $20 Million In Insider Spending Recently? - Mar 5th, 2025 1:34 am
Assembly Biosciences Doses First Participant in Phase 1a Clinical Study of Oral Entry Inhibitor Candidate ABI-6250 for Hepatitis Delta Virus - Feb 26th, 2025 1:00 pm
Assembly Biosciences Reports Positive Interim Phase 1a Results from Clinical Trial Evaluating Long-Acting Helicase-Primase Inhibitor ABI-1179 in Development for Recurrent Genital Herpes - Feb 20th, 2025 1:00 pm
Assembly Biosciences Reports Interim Phase 1b Results from Clinical Trial Evaluating Next-Generation Capsid Assembly Modulator Candidate ABI-4334 in Chronic Hepatitis B - Dec 26th, 2024 1:00 pm
Assembly Biosciences Announces $30.1 Million Equity Investment and Accelerated Funding from Gilead to Advance Clinical Development Programs - Dec 19th, 2024 1:00 pm
Bearish: Analysts Just Cut Their Assembly Biosciences, Inc. (NASDAQ:ASMB) Revenue and EPS estimates - Nov 13th, 2024 11:18 am
Assembly Biosciences: Q3 Earnings Snapshot - Nov 7th, 2024 11:19 pm